Meenal Mendiratta
Pediatric Endocrinology · Madera, CANPI 1487946091
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 26.4% of the total. Reporting peaked in 2019 at $635 and has fallen 72.9% since, to $172 in 2025.
Across 132 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$678
- Pfizer$188
- Ultragenyx Pharmaceutical Inc.$184
- Abbott$170
- Tandem Diabetes Care, Inc.$159
- Xeris Pharmaceuticals, Inc.$150
- plus $1K from 18 others
What the payments were for
- Food & beverage$2,42395%
- Education$1395%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $678 |
| Pfizer | 9 | $188 |
| Ultragenyx Pharmaceutical Inc. | 6 | $184 |
| Abbott | 11 | $170 |
| Tandem Diabetes Care, Inc. | 4 | $159 |
| Xeris Pharmaceuticals, Inc. | 8 | $150 |
| Biomarin Pharmaceutical Inc. | 4 | $129 |
| Novo Nordisk | 6 | $126 |
| Rhythm Pharmaceuticals, Inc. | 3 | $78 |
| Insulet Corporation | 5 | $77 |
| Lilly USA, LLC | 4 | $71 |
| Ipsen Biopharmaceuticals, Inc | 3 | $67 |
| Medtronic(2 entities) | 4 | $65 |
| Ascendis Pharma Endocrinology Inc | 3 | $63 |
| Neurocrine Biosciences, Inc. | 3 | $61 |
| Tolmar, Inc. | 2 | $52 |
| Vistapharm, Inc. | 2 | $44 |
| Dexcom, Inc. | 3 | $38 |
| Soleno Therapeutics, Inc. | 1 | $36 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| BD | 1 | $31 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| Lifescan, Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t-slim insulin pump$111
- Lupron Depot$110
- CRYSVITA$103
How this compares
$2,562 in reported general payments places this provider in the 60th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in Madera
- Jarreau Spencer ChenMadera$5K
- Omar AliMadera$5K
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Karen KleinSan Diego$195K
- Francine KaufmanLos Angeles$184K
- Lynda PolgreenOrange$167K
- Kevin KaisermanWest Covina$150K
- Amrit BhangooLong Beach$140K
- Mitchell GeffnerLos Angeles$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.